[ESPR] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -26.32%
YoY- -189.55%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 9,638 3,833 212,236 1,840 982 981 982 355.24%
PBT -104,476 -85,437 124,611 -78,249 -61,946 -68,377 -54,221 54.53%
Tax 8,795 4,970 4,721 4,539 5,165 5,383 0 -
NP -104,476 -85,437 124,611 -78,249 -61,946 -68,377 -54,221 54.53%
Tax Rate - - -3.79% - - - - -
Total Cost 114,114 89,270 87,625 80,089 62,928 69,358 55,203 61.91%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -1,084.00 -2,228.99 58.71 -4,252.66 -6,308.15 -6,970.13 -5,521.49 -66.05%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -3.89 -3.07 4.50 -2.84 -2.26 -2.52 -2.01 54.98%
EPS Diluted -3.89 -3.07 4.32 -2.84 -2.26 -2.52 -2.01 54.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.